3.1 Topline Results From a Phase 2 Adult and Adolescent Angelman Syndrome Clinical Trial: A Randomized, Double-Blind, Safety and Efficacy Study of Gaboxadol (Ov101)
2018 ◽
Vol 57
(10)
◽
pp. S182
Keyword(s):
Phase 2
◽